The Six-Year Arithmetic: Ruti Aga's Forged Prescription and the Clinic That Never Existed

Two years. Four years. Total six.

In the Ruti Aga case my eye stops first on that sum. The Athletics Integrity Unit statement records two separate violations with two separate penalties. One: a prohibited substance in a sample taken after she won a half marathon in China in March — two years. Two: producing a forged prescription and misleading statements during the investigation — four years. Six in all, running from 10 September, which is also the date her provisional suspension began.

For a 32-year-old marathoner the arithmetic reduces to a single sentence: the next time she stands on a start line she will be 38. Ethiopia's women's marathon depth has no room for a 38-year-old returnee, with a clean record or without. With a record, the room is zero.

Reading the statement at my desk in Bengaluru, an old habit surfaced — count first, then find the girl behind the count. The count here is clean. The story underneath is not.

Aga is no marginal name. She won the 2026 Tokyo Marathon, a World Marathon Major. Public records place her best level at roughly 2:18:34 in Berlin 2026, where she finished second, alongside three further second places at Majors. That is the profile of a runner who builds a career sitting just below the podium — in Ethiopia that reads as "very good", not "selectable".

The statement gives no performance number at all. No time from the March Chinese half marathon, no splits, no field quality, and, remarkably, no year for the race. What exists is only this much: she won it and her sample came back positive. What does not exist is whether the result and prize money were annulled. Standard AIU practice disqualifies the competition at which the sample was collected. The statement is silent on that line. The silence belongs to the statement, not the reporting — and it will decide whether her 2026 Tokyo title survives.

It should survive. The violation is anchored to a later race and the statement does not reach backwards. A 2:18 performance does not carry a runner into Ethiopia's national team; the world-record level has already been reached and several athletes sit beneath it. Aga's removal changes nothing at the level of national strength. This case is small as sport and very large as governance.

A technical correction is necessary here, because the substance has been carried under the wrong name. Methylprednisolone is not an anabolic steroid. It is a glucocorticoid, class S9 on the WADA Prohibited List. Anabolic steroids sit in S1. The distinction is technical and the consequence is not.

S9 glucocorticoids are prohibited in-competition only — and only by injection, oral or rectal route. An injection given out of competition is, in itself, lawful. That is the point on which this case turns: route and timing. Intra-articular methylprednisolone for knee synovitis is routine sports medicine for distance runners. Knowing this matters, because the legitimacy of the treatment left her a real defence — and she destroyed it herself with a forged document.

What did that defence look like? Three things. One, genuine medical records. Two, a TUE — a therapeutic use exemption. Three, a documented calculation of route and timing, meaning enough gap between injection and race. None of the three happened. What happened instead is a chain of three separate verification failures.

First: the clinic named on the prescription did not exist. Second: the person who wrote it was a family member with no medical registration. Third: that person claimed to have used "an old prescription pad from a former workplace" — and the clinic itself disowned the claim.

The two-year penalty sits on the substance; the remaining two-thirds of the six years sits on paper. That is the actual architecture of this case. And the architecture exposes a medical gap that anti-doping reports tend to settle in a single line: the athlete had no team physician at all.

This is where my 2026 series "Empty Stands" comes back to me. That series is where I began covering contracts, pay bands and leave rules with the seriousness others reserve for form. I learned then that "a stable job" is half the truth; "a sports-quota post in the 4200-grade" is the whole of it. The same applies here. "A family member wrote the prescription" is the essence of medical disorder. It is bigger than an administrative slip. It is the signature of an athlete standing alone in the middle of a market without any credentialed support structure.

There is a fourth point, technical in the statement and political in the reporting. The four-year tampering sanction does not come from a document. It comes from an interview — from statements made under questioning. Language and translation conditions in AIU interviews with East African athletes have been a recurring point of contention. I am not alleging a procedural failure here; I am saying that when a large share of a sanction is decided through language, the transcript should be public.

The case also has an economy, and it is the least reported part. After 2026 Aga's calendar followed the standard pattern for 2:18–2:20 East African marathoners: selected Majors, with Asian label races in between. The Chinese half-marathon circuit is the most lucrative segment of that model — good appearance fees, low risk, low travel. It is also now the AIU's highest-yield testing ground. The appearance-fee economy and the testing economy are colliding in the same races — and the bill for the collision is being paid by one athlete alone.

Now the part that makes both the statement and the coverage uncomfortable.

A six-year ban rests on a substance with no proven endurance benefit. A glucocorticoid reduces pain and swelling; it does not raise VO2max. By calling it a "steroid", the media pulled the case into a category where six years sounds reasonable. That category is wrong.

I have no objection to four years for the forgery. My objection is that the public story glued two separate things onto one label: a therapeutic substance present at the wrong time, and a fabricated document. The AIU weighed them separately — two and four. The headline made them one. When two-thirds of a sanction is about paper, is this a doping case or a documentary offence?

The second discomfort is larger. The statement contains one name: the family member. The names it does not contain are the agent, the manager, the coach, the physio. The structure that allowed this athlete to operate without a team doctor, without a TUE process, without any lawful advice is simply absent from the statement. The sanction rests entirely on one person. Accountability rests on nobody.

I have seen this pattern before. At the 2026 Under-17 World Cup I ran a count of my own — how many women worked in technical areas across 52 matches. The number fitted on one line, and my editor spiked it as "too niche". That day I decided I would write counts, not inspiration. The count in this case reads: one athlete, six years, zero officials.

Someone will say Aga derailed herself. True. She submitted the forged prescription, whether or not someone placed it in her hand. But when cases of this shape keep arriving out of Ethiopia's road-racing system, the question has to travel past the individual. Tampering is now among the most common secondary charges in this region. That is not coincidence. It is infrastructure.

A 32-year-old runner, three Major podiums, one Major title, and finally a ban that ends a career at 38. This is not a fourth place. This is the point at which the count runs out.

In my next report I will add one more column to the Parity Ledger, the one still empty: a comparison of sanctions handed to male and female athletes in anti-doping cases, and how many of them saw action against an agent or manager. If that number also fits on one line, the question will not be for the AIU. It will be for us.

The spreadsheet was my map; the destination is always a girl. This time she is standing outside the start line at 38, asking: the prescription that cost me my career — which column records the accountability of the person who wrote it?